- Home
- APLT vs JAKK Comparison
APLT vs JAKK Comparison
Compare APLT & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- JAKK
- Stock Information
- Founded
- APLT 2016
- JAKK 1995
- Country
- APLT United States
- JAKK United States
- Employees
- APLT N/A
- JAKK N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- JAKK Recreational Games/Products/Toys
- Sector
- APLT Health Care
- JAKK Consumer Discretionary
- Exchange
- APLT Nasdaq
- JAKK Nasdaq
- Market Cap
- APLT 178.6M
- JAKK 206.8M
- IPO Year
- APLT 2019
- JAKK 1996
- Fundamental
- Price
- APLT $1.28
- JAKK $18.42
- Analyst Decision
- APLT Buy
- JAKK Strong Buy
- Analyst Count
- APLT 5
- JAKK 4
- Target Price
- APLT $4.13
- JAKK $37.75
- AVG Volume (30 Days)
- APLT 5.5M
- JAKK 90.4K
- Earning Date
- APLT 11-10-2025
- JAKK 10-30-2025
- Dividend Yield
- APLT N/A
- JAKK 5.35%
- EPS Growth
- APLT N/A
- JAKK 25.15
- EPS
- APLT N/A
- JAKK 3.34
- Revenue
- APLT $121,000.00
- JAKK $684,694,000.00
- Revenue This Year
- APLT N/A
- JAKK N/A
- Revenue Next Year
- APLT $5,935.35
- JAKK $4.06
- P/E Ratio
- APLT N/A
- JAKK $5.59
- Revenue Growth
- APLT N/A
- JAKK 1.31
- 52 Week Low
- APLT $0.30
- JAKK $16.24
- 52 Week High
- APLT $10.62
- JAKK $35.79
- Technical
- Relative Strength Index (RSI)
- APLT 60.36
- JAKK 45.98
- Support Level
- APLT $1.16
- JAKK $18.86
- Resistance Level
- APLT $1.50
- JAKK $19.75
- Average True Range (ATR)
- APLT 0.14
- JAKK 0.68
- MACD
- APLT -0.02
- JAKK -0.09
- Stochastic Oscillator
- APLT 61.64
- JAKK 36.85
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.